CClinicalTrials.gg
Status unknownNCT04986059Updated Aug 2, 2021

Effects of Pre-event Massage on Muscle Activity

An interventional study of Pre-event massage in Neuromuscular Diseases, sponsored by Universitat Internacional de Catalunya. Status unknown at 1 site in Spain. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-02.

Sponsored by Universitat Internacional de Catalunya · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The study observes the effect of a pre-event massage on the gastrocnemius and Hamstring muscles on muscle activity.

02

Conditions studied

  • Neuromuscular Diseases

Keywords

  • Pre-competition massage
  • Pre-event massage
  • Gastrocnemius
  • Superficial Electromyography
  • Hamstrings
03

In context

Neuromuscular Diseases

300 studies on the registry are indexed under Neuromuscular Diseases; 87 are open to participants now.

This study's planned enrollment of 60 is above the median of 32 across 168 interventional studies indexed under Neuromuscular Diseases.

Browse Neuromuscular Diseases studies →

Lead sponsor

Universitat Internacional de Catalunya is the lead sponsor of 144 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

-

Exclusion Criteria:

  • Muscle injury in the last two months
  • Suffer a musculoskeletal disorder that doesn't allow the subject to do the study protocol
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Pre-event massage

    Other: Pre-event massage

  • No intervention
    Control

Interventions

  • OtherPre-event massage

    Five minutes massage, combining superficial and high-frequency techniques of massage applied with the therapist hands on gastrocnemius and hamstring muscles

06

What researchers measure

Primary outcomes

  1. Muscle activity (microVolts)

    sEMG is a NON-invasive method that measures the electrical activity of the muscle generated by the passage of the nerve impulse, which causes depolarization of the muscle cell membrane during excitation. Once the muscle is contracted and receives electrical signals, the electrodes pick up these signals and record them on the device application.

    Time frame: Change between baseline(immediately before intervention) and post intervention (immediately after intervention

Secondary outcomes

  1. Jump Force (Newtons)

    Jump Force will be measured using the Myjump app

    Time frame: Change between baseline(immediately before intervention) and post intervention (immediately after intervention)

  2. Jump speed (m/s)

    Jump Speed will be measured using the Myjump app

    Time frame: Change between baseline(immediately before intervention) and post intervention (immediately after intervention)

  3. Jump Height (cm)

    Jump Height will be measured using the Myjump app

    Time frame: Change between baseline(immediately before intervention) and post intervention (immediately after intervention)

07

Study locations

1 of 1 sites recruiting
  • Universitat Internacional Catalunya
    Barcelona, Sant Cugat 08195, Spain
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04986059
Lead sponsor
Universitat Internacional de Catalunya
Responsible party
Albert Pérez Bellmunt (Principal Investigator, Universitat Internacional de Catalunya) — Principal investigator
First posted
Aug 2, 2021
Start date
Oct 2021 (estimated)
Primary completion
Mar 2022 (estimated)
Completion
Apr 2022 (estimated)
Last update
Aug 2, 2021

Study contacts

Albert Pérez-Bellmunt
Contact
aperez@uic.cat
636817297 ext. +34

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion